Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6823706

N.c1cc2cc(c1)CCC2

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
MME P08473 4/20 0.30
ACE P12821 4/20 0.30
ECE1 P42892 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14811593 0.97
SCHEMBL31557611 0.94 TSHR (0.38) TSHRMMEACEECE1
SCHEMBL31557612 0.88 TSHR (0.38) TSHRMMEACEECE1
Ammonia Solution, Strong SCHEMBL2457320 0.87
SCHEMBL25365911 0.83 NR1H2 (0.34) TSHR
SCHEMBL1760719 0.83 NR1H2 (0.34) TSHR
Dimethylamine SCHEMBL29203962 0.73 ACHE (0.32)
SCHEMBL27603876 0.71 CCNB2 (0.31)
SCHEMBL9566479 0.70 ACHE (0.43) MMEACEECE1
Ammonia Solution, Strong SCHEMBL3063865 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119543-B1 N-ARALKYLAMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR ORTHO MCNEIL PHARM INC (US) 2004-12-15 EP disclosed
EP-1119543-A1 N-ARALKYLAMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR Ortho-McNeil Pharmaceutical, Inc. (US) 2001-08-01 EP disclosed
US-6201025-B1 FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-03-13 US disclosed
WO-2000020376-A1 N-ARALKYLAMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-04-13 WO disclosed